{"id":"W2247329814","doi":"10.1200/jco.2005.23.16_suppl.3583","title":"An open-label multicenter phase II study of oral lapatinib (GW572016) as single agent, second-line therapy in patients with metastatic colorectal cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Lapatinib; Internal medicine; Irinotecan; Rash; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Discontinuation; Adverse effect; Nausea; Oxaliplatin; Phases of clinical research; Colorectal cancer; Oncology; Cancer; Surgery; Chemotherapy; Breast cancer; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010932,0.0002103256,0.001898206,0.0001304651,0.00006394205,0.00001175412,0.0002316536,0.000100296,0.0006709559],"category_scores_gemma":[0.0003349693,0.0001233428,0.00009919966,0.0001808154,0.000150134,0.0002722285,0.00009312866,0.0004704014,0.000002654215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002841492,"about_ca_system_score_gemma":0.0006841884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002508485,"about_ca_topic_score_gemma":0.007099533,"domain_scores_codex":[0.996636,0.0004419313,0.002008334,0.0002670632,0.0003982514,0.0002484258],"domain_scores_gemma":[0.9969273,0.0004367827,0.001574202,0.0001659244,0.000644671,0.000251093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1151157,0.1829477,0.2992717,0.000008915938,0.001477119,0.0001611117,0.001657539,0.00001576912,0.0002221323,0.000001343619,0.0003031788,0.3988177],"study_design_scores_gemma":[0.161742,0.4705466,0.362085,0.00005533608,0.0003860588,0.000008221867,0.0005329325,0.00006143431,0.0001670867,0.000005558226,0.004316115,0.00009363142],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966775,0.0002793628,0.000001968978,0.0008923151,0.000393979,0.001252694,0.00002496846,0.000004897456,0.0004722729],"genre_scores_gemma":[0.996607,0.0001749899,0.001642069,0.00117245,0.0001850747,0.0000429458,0.000006483334,0.00002309769,0.000145902],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3987241,"threshold_uncertainty_score":0.7346497,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1988514400215738,"score_gpt":0.5231931102536629,"score_spread":0.3243416702320892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}